Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
Year-over-year earnings per share growth rate
Latest
49.41%
↑ 496% vs avg
Percentile
P95
Near historical high
Streak
1 qtr
Consecutive growthAccelerating
Average
-12.48%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 49.41% |
| Q3 2025 | -167.37% |
| Q2 2025 | 42.77% |
| Q1 2025 | -22.51% |
| Q4 2024 | 44.92% |
| Q3 2024 | 30.70% |
| Q2 2024 | 3.79% |
| Q1 2024 | -29.93% |
| Q4 2023 | -6.37% |
| Q3 2023 | -13.86% |
| Q2 2023 | -10.87% |
| Q1 2023 | 15.06% |
| Q4 2022 | -4.84% |
| Q3 2022 | -14.73% |
| Q2 2022 | -23.21% |
| Q1 2022 | 11.11% |
| Q4 2021 | 0.26% |
| Q3 2021 | -1.88% |
| Q2 2021 | -12.05% |
| Q1 2021 | 13.09% |
| Q4 2020 | -1.87% |
| Q3 2020 | -17.92% |
| Q2 2020 | -35.90% |
| Q1 2020 | -30.00% |
| Q4 2019 | -29.50% |
| Q3 2019 | -8.59% |
| Q2 2019 | -30.61% |
| Q1 2019 | -30.67% |
| Q4 2018 | -33.93% |
| Q3 2018 | -24.44% |
| Q2 2018 | 0.00% |
| Q1 2018 | 32.84% |
| Q4 2017 | 1.47% |
| Q3 2017 | 1.45% |
| Q2 2017 | -38.00% |
| Q1 2017 | 25.37% |
| Q4 2016 | 57.86% |
| Q3 2016 | 90.26% |
| Q2 2016 | -68.00% |
| Q1 2016 | -262.69% |